Literature DB >> 2161369

Reovirus type 2-induced diabetes in mice prevented by immunosuppression and thymic hormone.

T Onodera1, T Taniguchi, K Yoshihara, S Shimizu, M Sato, T Hayashi.   

Abstract

Reovirus type 2 that had been isolated from a cow with diarrhoea and passaged in bovine kidney cell culture produced a Type 1 (insulin-dependent) diabetes-like syndrome when inoculated into NC mice. The infection resulted in insulitis and destruction of islet cells. Viral antigens were found in islet cells by staining with fluorescein-labelled antibody to reovirus type 2. The destruction of islet cells resulted in abnormalities shown on glucose tolerance testing. Studies on the susceptibility of the host showed that only certain strains of mice had overtly abnormal glucose tolerance tests when infected with reovirus type 2. To assess the immunological role in the pathogenesis of reovirus type 2-induced diabetes, infected mice were subjected to immunosuppressive or thymic hormone treatment. The administration of either anti-thymocyte serum or serum thymic factor reduced or prevented the development of the diabetes-like syndrome, while Arg-Lys-Asp-Val-Try did not show any therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161369     DOI: 10.1007/BF00404795

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  [Increase in activity of natural killer cells (NK cells) by serum thymic factor].

Authors:  P Bardos; C Carnaud; J F Bach
Journal:  C R Seances Acad Sci D       Date:  1979-12-17

Review 2.  Virus-induced diabetes mellitus.

Authors:  A L Notkins
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  Serological relationship between Japanese strains of reovirus of bovine origin and type 2 reovirus strains.

Authors:  H Kurogi; Y Inaba; E Takahashi; K Sato; T Omori
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1980

4.  Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression.

Authors:  T Onodera; U R Ray; K A Melez; H Suzuki; A Toniolo; A L Notkins
Journal:  Nature       Date:  1982-05-06       Impact factor: 49.962

5.  Intensive suppression of experimental allergic encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for multiple sclerosis.

Authors:  Y Nagai; T Osanai; K Sakakibara
Journal:  Jpn J Exp Med       Date:  1982-08

6.  Coxsackie viruses and diabetes mellitus.

Authors:  D R Gamble; K W Taylor; H Cumming
Journal:  Br Med J       Date:  1973-11-03

7.  Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus.

Authors:  K Buschard; S Madsbad; J Rygaard
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

8.  Prolongation of murine skin grafts by FTS and its synthetic analogues.

Authors:  D Kaiserlian; A Dujic; M Dardenne; J F Bach; D Blanot; E Bricas
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

9.  Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus.

Authors:  M Horita; H Suzuki; T Onodera; F Ginsberg-Fellner; A S Fauci; A L Notkins
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

10.  Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4.

Authors:  J W Yoon; T Onodera; A L Notkins
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  7 in total

1.  Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1.

Authors:  T Hayashi; S Yamamoto; T Onodera
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

2.  In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice.

Authors:  M Mizutani; M El-Fotoh; M Mori; K Ono; K Doi; A Awaya; Y Matsumoto; Y Matsumoto; T Onodera
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Reovirus delays diabetes onset but does not prevent insulitis in nonobese diabetic mice.

Authors:  J Denise Wetzel; Erik S Barton; James D Chappell; Geoffrey S Baer; Michelle Mochow-Grundy; Steven E Rodgers; Yu Shyr; Alvin C Powers; James W Thomas; Terence S Dermody
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice.

Authors:  T Hayashi; K Yoshinaka; K Hasegawa; K Maeda; T Onodera
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

5.  Reovirus type-2 infection in newborn DBA/1J mice reduces the development of late allergic asthma.

Authors:  Tomomi Nakashima; Toshiharu Hayashi; Takuya Mizuno
Journal:  Int J Exp Pathol       Date:  2012-06       Impact factor: 1.925

6.  Interleukin-4-expressing plasmid DNA inhibits reovirus type-2-triggered autoimmune insulitis in DBA/1 J suckling mice.

Authors:  T Hayashi; Y Yasutomi; K Hasegawa; Y Sasaki; T Onodera
Journal:  Int J Exp Pathol       Date:  2003-04       Impact factor: 1.925

Review 7.  Dual role of cellular prion protein in normal host and Alzheimer's disease.

Authors:  Takashi Onodera
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.